BIOTIME Financial Statements From 2010 to 2026

Stocks . Germany . 
Stock . BIOTIME
BT3 Stock  EUR 1.35  0.00  0.00%   
BIOTIME's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing BIOTIME's valuation are provided below:
Market Capitalization
298.5 M
Enterprise Value Revenue
29.2936
There are over fifty-nine available fundamental signals for BIOTIME, which can be analyzed over time and compared to other ratios. Investors should ensure to validate all of BIOTIME's prevailing performance against the performance from 2010 to 2026 to make sure the company is sustainable for few more years.

BIOTIME Total Revenue

6.81 Million

Check BIOTIME financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among BIOTIME's main balance sheet or income statement drivers, such as Tax Provision of 0.0, Net Interest Income of 2.1 M or Interest Expense of 0.0, as well as many indicators such as . BIOTIME financial statements analysis is a perfect complement when working with BIOTIME Valuation or Volatility modules.
  
This module can also supplement various BIOTIME Technical models . Check out the analysis of BIOTIME Correlation against competitors.

BIOTIME Balance Sheet

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Total Assets103.4 M101.9 M130.8 M
Slightly volatile
Other Current Liabilities354.4 K337.5 K317.5 K
Pretty Stable
Total Current Liabilities16.5 M16.1 M13 M
Slightly volatile
Total Stockholder Equity79.2 M70.5 M102.8 M
Slightly volatile
Accounts Payable2.3 M1.4 M1.9 M
Slightly volatile
Cash33.4 M52.7 M28.9 M
Slightly volatile
Non Current Assets Total61.9 M56 M89.2 M
Slightly volatile
Non Currrent Assets Other525 K552.6 K63.9 M
Slightly volatile
Long Term Debt15.4 K16.2 K484.7 K
Slightly volatile
Net Receivables697 K733.7 K3.5 M
Pretty Stable
Short Term Investments2.2 M2.3 M5.8 M
Slightly volatile
Non Current Liabilities Total16.3 M25.6 M11.4 M
Slightly volatile
Capital Lease Obligations3.2 M2.9 M2.6 M
Slightly volatile
Total Liabilities32.8 M41.6 M24.4 M
Slightly volatile
Short and Long Term Debt335.4 K470.7 K628.8 K
Slightly volatile
Total Current Assets57.1 M58.6 M43.3 M
Slightly volatile
Non Current Liabilities Other1.7 K1.8 K59.4 K
Very volatile
Short Term Debt59.9 K63 K428.8 K
Slightly volatile
Intangible Assets36.9 M53.5 M26.7 M
Slightly volatile
Common Stock Shares Outstanding177.6 M253.5 M153.6 M
Slightly volatile
Net Invested Capital77.4 M70.5 M121.3 M
Slightly volatile
Net Working Capital31.5 M33.3 M37.1 M
Very volatile
Capital Stock463 M557.4 M400 M
Slightly volatile
Property Plant And Equipment Net4.5 M4 M6.8 M
Slightly volatile
Good Will8.5 M9.6 M10.5 M
Slightly volatile
Other Current Assets1.9 M2.3 M2.6 M
Slightly volatile
Property Plant And Equipment Gross10.5 M10.1 M8.9 M
Slightly volatile

BIOTIME Income Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Selling General Administrative16.8 M16.4 M23.1 M
Slightly volatile
Total Revenue6.8 M10.9 M6.4 M
Slightly volatile
Gross Profit6.2 M10.5 M5.9 M
Slightly volatile
Research Development16.7 M11.2 M25.4 M
Slightly volatile
Cost Of Revenue584.7 K384.1 K464.8 K
Slightly volatile
Total Operating Expenses33.7 M27.9 M48.9 M
Slightly volatile
Reconciled Depreciation520.7 K548.1 K2.3 M
Slightly volatile
Interest Income1.1 M2 M1.1 M
Slightly volatile

BIOTIME Cash Flow Statement

Trends
Current ValueLast YearHistorical Average 10 Year Trend
Depreciation520.7 K548.1 K2.9 M
Slightly volatile
Capital Expenditures856.4 K508.5 K1.5 M
Slightly volatile
Total Cash From Financing Activities18.2 M32.3 M26.6 M
Slightly volatile
End Period Cash Flow33.9 M53.3 M29.2 M
Slightly volatile
Begin Period Cash Flow31.9 M41.4 M27 M
Slightly volatile
Issuance Of Capital Stock43.3 M41.3 M12.8 M
Slightly volatile
Stock Based Compensation4.3 M5.8 M3.9 M
Slightly volatile

About BIOTIME Financial Statements

BIOTIME stakeholders use historical fundamental indicators, such as BIOTIME's revenue or net income, to determine how well the company is positioned to perform in the future. Although BIOTIME investors may analyze each financial statement separately, they are all interrelated. For example, changes in BIOTIME's assets and liabilities are reflected in the revenues and expenses on BIOTIME's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in BIOTIME. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Total Revenue10.9 M6.8 M
Cost Of Revenue384.1 K584.7 K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.
FSLYFastly Class A
MOBMobilicom Limited American
CMGChipotle Mexican Grill

Other Information on Investing in BIOTIME Stock

BIOTIME financial ratios help investors to determine whether BIOTIME Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in BIOTIME with respect to the benefits of owning BIOTIME security.
Balance Sheet
Statement
Details
Profit & Loss
Statement
Details
Cash Flow
Statement
Details
Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions
 
Feedback Blog
Made with optimal in San Francisco
2026 Macroaxis LLC
COMMON DESTINATIONS
MAIN CATEGORIES
COMPANY